Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy

Diabetes Obesity and Metabolism(2024)10.1111/dom.15798Source: DataRank Database

Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy is a research paper published in Diabetes Obesity and Metabolism (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.53)OA: bronzeTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Andrea Bellavia ORCID,David D. Berg ORCID,Giorgio Melloni ORCID,Mark W. Feinberg ORCID,Lawrence A. Leiter ORCID

Live enrichment

PubMed:39056220 PMC:PMC11410501 OpenAlex:https://openalex.org/W4401033823

American Heart Association

Grant: 20SFRN35120087

National Heart, Lung, and Blood Institute

Grant: T32HL007604

FWCI

0.53

Citation Percentile

0.7%

Citation Trend

2025

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15798

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15798

publisherhttps://dom-pubs.pericles-prod.literatumonline.com/doi/pdf/10.1111/dom.15798

journalhttps://doi.org/10.1111/dom.15798

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39056220

Fields of Study

Diabetes Treatment and ManagementBariatric Surgery and OutcomesPharmacology and Obesity Treatment

MeSH Terms

AgedDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedObesityRisk FactorsWeight LossBody Mass IndexTreatment OutcomeRisk AssessmentAnti-Obesity Agents

Keywords

MedicinePharmacotherapyWeight lossDiabetes mellitusIntensive care medicineType 2 diabetesInternal medicineObesityEndocrinologyCardiovascular diseaseEffectivenessRandomised TrialAntiobesity Drug

Sustainable Development Goals

SDG 0: Peace, Justice and strong institutions